Mechanism of action and resistance to Trastuzumab Deruxtecan in patients with metastatic breast cancer
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
A phase II clinical trial (NCT04132960) of 179 breast cancer patients. Whole-exome sequencing is available for 110 tumor samples and 85 blood samples. The samples were collected at entry into the trial for 89 patients and upon progression for 21 patients, with 11 patients sampled at both time points.EGA study EGAS00001007372
创建时间：
2023-06-28
